Clinical Trials

» COLON CANCER
» BLADDER CANCER
» HEAD & NECK CANCER
» BREAST CANCER
» GENITOURINARY
» LUNG CANCER
» SKIN CANCER
» BLOOD DISORDER
» PROSTATE CANCER

COLON CANCER

N08CB A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity.
(Project 960)
Eric Bravin, M.D.


Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. Christina.bourgeois@bassett.org 607-547-6373


BLADDER CANCER

Currently, no trials


HEAD & NECK CANCER

E1305: Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
(Project 996)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois R.N. christina.bourgeois@bassett.org 607-547-6373

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT)
+/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
(Project 993)
Timothy Campbell, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois R.N. christina.bourgeois@bassett.org 607-547-6373


BREAST CANCER

NSABP B-47: A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
(Project 975)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, R.N. christina.bourgeois@bassett.org 607-547-6373
 

NSABP B-43: A Phase III clinical trial comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER-2 Positive Ductal Carcinoma In Situ Resected by Lumpectomy.
Eric Bravin, M.D.


Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. Christina.bourgeois@bassett.org 607-547-6373

NSABP B-39: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer.
Eric Bravin, M.D.


Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. Christina.bourgeois@bassett.org 607-547-6373

SCUSF 0806: Phase II placebo-controlled trial of lisinopril and Coreg CR® to reduce cardiotoxicity in patients with breast
(Project 977)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. Christina.bourgeois@bassett.org 607-547-6373


GENITOURINARY

S0931: “EVEREST”: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

(Project 983)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois R.N. christina.bourgeois@bassett.org 607-547-6373


LUNG CANCER

CALGB 30607: Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer.
(Project 940)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. christina.bourgeois@bassett.org 607-547-6373
 

E5508: Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
(Project 999)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. christina.bourgeois@bassett.org 607-547-6373


PROSTATE CANCER

Currently, no trials


METASTATIC CANCER

 

E2108:  A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
(Project 1009)
Eric Bravin, M.D.

Trial Contact Information:
Diana Crean diana.crean@bassett.org 607-547-3073
Christina Bourgeois, B.S., R.N. christina.bourgeois@bassett.org 607-547-6373
 


SKIN CANCER

Currently, no trials


BLOOD DISORDER

Currently, no trials

Network Calendar

May 2012

S M T W T F S
  12345
6789101112
13141516171819
20212223242526
2728293031  

Calendar Search



Date Range